Request a quote
All products
Active Pharmaceutical IngredientsPharmaceutical IntermediatesVeterinary APIsPharmaceutical Packaging
Quality & compliance Resources About Contact
ENESFRRU
Request a quote

Tilmicosin Phosphate

Tilmicosin phosphate salt, 20-deoxo-20-(3,5-dimethylpiperidin-1-yl)desmycosin phosphate · CAS 137330-13-3

Veterinary Veterinary grade / EP (vet) CoA per batchSDSMRL guidance note

A semi-synthetic macrolide with a narrow safety margin in horses, so species labelling has to be explicit. Assay is expressed on the base, and the phosphate counter-ion is confirmed separately.

Part of the veterinary antibacterial line. Withdrawal periods and MRL guidance are part of the supply conversation, not an afterthought.

Identity

Catalogue no.BP-VET-017
CAS number137330-13-3
Molecular formulaC46H80N2O13 · H3PO4
Molecular weight967.14 g/mol
HS code2941.90
SynonymsTilmicosin phosphate salt, 20-deoxo-20-(3,5-dimethylpiperidin-1-yl)desmycosin phosphate
Product lineVeterinary APIs
CategoryVeterinary Antibacterials

Release specification

Catalogue standard below. For a supply agreement we release against your dossier specification; send it with the enquiry and the CoA will be built around it.

ParameterSpecification
Assay≥ 85.0%
Related substancesTilmicosin base ≥ 85.0% (on dried basis); any unspecified impurity ≤ 1.0%
Water content≤ 0.5% (Karl Fischer)
Heavy metals≤ 20 ppm (ICP-MS)
pH (10% suspension)5.0–7.5

Application

Macrolide for bovine and swine respiratory disease, given by injection or in feed.

Packaging, storage & logistics

Standard packaging25 kg fibre drum with double PE liner
Minimum order25 kg
Lead time25–40 days
Storage conditionsStore below 25 °C, protected from light
Shipping documentsInvoice, packing list, CoA, SDS, certificate of origin; DGM/IATA declaration where applicable

Pack sizes available — pick one to prefill the enquiry

100 g1 kg25 kg500 kg

Documentation provided

  • CoA per batchBatch-specific, tested against the specification agreed at PO stage
  • SDSCurrent GHS revision; destination-language version on request
  • MRL guidance noteMaximum residue limit and withdrawal-period reference for the destination market

Need the DMF open part, a sample CoA or an audit pack before you can qualify us? Ask on the enquiry form — we send those documents before any commercial discussion.

Request a quotation

Submitting opens your email client with these details filled in, so the enquiry reaches gm@bioranpharma.com directly. We use your details only to answer this enquiry — see privacy & data use.

Related products